Latest Videos |view all videos
A Comprehensive Overview of Tumor-Infiltrating Lymphocyte (TIL) Therapy for Metastatic Melanoma
Tuesday, April 9, 2024 5:30 - 6:30 PM EDT - On the heels of the FDA’s recent approval of AMTAGVI (lifileucel) for unrescectable or metastatic melanoma, join Roswell Park subject matter experts for a comprehensive provider education event.
Aggressive Breast Cancer Strains Found in Younger Patients
Breast cancer in young adults is a rare disease, with 5% of new patients diagnosed with the disease under the age of 40.
Gynecologic Malignancies in Young Adults
Gynecologic malignancies such as cervical, ovarian, and endometrial cancers found in young adult patients often present with several additional challenges compared to their older cohorts.
Dermatology and Mohs Surgery Options for Younger Patients with Skin Cancer
Melanoma and non-melanoma skin cancers are some of the most commonly diagnosed malignancies in young adults, and melanomas tend to be more aggressive in this demographic.
Meet the Team: Shernan Holtan, MD
The newest member of the cellular therapy research team and Chief of the Bone Marrow and Transplantation Service at Roswell Park Comprehensive Cancer Center is eager to continue advancing the field.
With a focus on immunotherapy, CAR T-cell therapy and bispecific treatments, Dr. Niu believes a more direct, targeted approach will become the gold standard for leukemia and other diseases in the near future, offering patients a better quality of life.
Meet the Team: Dr. Ehsan Malek
As the Director of the Multiple Myeloma Translational Research Program at Roswell Park, Dr. Malek brings with him a passion for finding new and innovative treatments for this disease and other plasma cell disorders
Diagnosis and Co-management of Hematologic Malignancies for the Primary Care Provider
Our expert speakers dive into the latest techniques in diagnostics, treatment modalities, and interdisciplinary approaches, providing attendees with valuable insights to enhance patient care and outcomes.
Hyperparathyroidism Reveals Two Malignancies in 27-Year-Old Patient
Gary Mann, MD, FACS, Professor of Oncology in the Department of Surgical Oncology at Roswell Park Comprehensive Cancer Center, recounts an unexpectedly complicated series of surgeries performed on a 27-year-old patient, initially examined for hypercalcemia.